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PSN
(n=19)
non-PSN
(n=24) p-value
IVUS ﬁndings
LM EEM CSA, mm 2 14.3  4.9 15.5  4.4 0.41
Lumen CSA, mm2 3.7  1.3 3.8  0.8 0.7
Plaque area, mm2 10.6  4.5 11.7  4.1 0.43
LAD EEM CSA,
mm2
12.3  3.8 14.9  3.4 0.03
Lumen CSA, mm2 4.7  1.4 5.6  2.2 0.11
Plaque area, mm2 7.6  4.0 9.4  2.8 0.11
LCx EEM CSA, mm2 10.0  2.8 11.7  3.3 0.11
Lumen CSA, mm2 5.7  2.1 6.9  2.8 0.16
Plaque area, mm2 4.3  1.7 4.8  1.6 0.41
Plaque morphology
Calciﬁed plaque, %
78.9 16.7 p<0.01
Fibrous plaque, % 5.2 54.2
Soft plaque, % 15.8 29.2
Arc of Calcium,
degree
105.1  65.5 17.2  43.3 p<0.01
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LCx narrowing after LAD crossover stenting in ULMCA.
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Background: Previous study reported jailed strut at side branch oriﬁce (SO) may be
a cause of delayed tissue coverage and thrombus formation after single stenting to
bifurcation. We assessed the neointimal coverage of jailed strut in four different types
of drug-eluting stent (DES).
Methods: Total of 78 true bifurcation lesions treated by single stenting using 27
sirolimus-eluting stent (SES), 17 paclitaxel-eluting stent (PES), 21 everolimus-eluting
stent (EES), and 14 biolimus-eluting stent (BES) without ﬁnal kissing inﬂation
underwent optical coherence tomography imaging at mid-term follow up after
implantation (82 months). We evaluated neointimal thickness on jailed strut (Jail-
NIT), whole tissue thickness surrounding jailed strut (jailed struts complex; JSC) and
frequency of thrombus attachment. We also classiﬁed JSC into four groups according
to the surface (regular / irregular) and morphology (homogeneous / heterogeneous).
Results: Jail-NIT was thicker in SES and thinner in PES (SES: 68.247.1mm, PES:
25.636.3mm, EES: 57.844.6mm, BES 60.129.2mm, P<0.05). Thickness of JSC
in SES showed thicker than other three DES. JSC in EES and BES showed
predominantly regular and homogeneous compared with that in SES and PES (ﬁgure).
Thrombus on jailed strut was most frequently detected in SES (SES: 9/27, PES: 4/17,
EES: 1/21, BES: 1/13 P<0.05).JACC Vol 62/18/Suppl B j October 27–November 1, 2013 j TCT AbstrConclusions: Although SES and PES show various tissue attachment on jailed strut
with higher incidence of thrombus, EES and BES seems to develop less thrombogenic
stable neointimal coverage. This suggests a potential beneﬁt of EES or BES
implantation to bifurcation lesion.
TCT-574
First Randomized Evaluation of the Extent of Neointimal Formation between
Two Types of Sirolimus-Eluting Stents with Different Designs on Biodegradable
Polymer Coatings: The BuMA-OCT Trial
Yuejin Yang1, Hongbing Yan1, Zhongwei Sun1, Yelin Zhao1, Yida Tang1, Zhan Gao1,
Jue Chen1, Jingang Cui1, Bo Xu1
1Fu Wai Hospital, National Center for Cardiovascular Diseases, China, Beijing,
China
Background: Biodegradable polymer drug-eluting stents (BPDES) have been
developed to address the risk of stent thrombosis. The EXCEL stent (JW Medical
Systems, Weihai, China) features an abluminal PLA drug carrier which enables a 6-9
month 100% drug release in vivo. The BuMA stent (Sino Medical, Tianjin, China)
features an electro-grafting (eG) base layer and a PLGA drug carrier. The eG layer
secures adhesion of the biodegradable PLGA coating as a result of the interdigitation,
and the PLGA coating ensures 100% drug release proﬁle in 30 days. We aimed to
compare 3-month neointimal formation by using optical coherence tomography
(OCT) between the two BPDES, which are both based on the stainless steel platform,
releasing sirolimus, but with different coating designs.
Methods: Patients with clinical evidence of myocardial ischemia were recruited in
this prospective, single center, randomized, non-inferiority trial in 1:1 fashion. All
patients were required to undergo OCT and angiographic follow-up at 3 months after
intervention. Neointimal growth was analyzed at each stent strut of cross-sectional
OCT images with 0.5mm intervals. The primary endpoint is the proportion of fully
covered stent struts (%) at 3 months. Secondary endpoints include neointimal thick-
ness, stent strut malapposition, and angiographic late lumen loss. If non-inferiority of
the primary endpoint is met, superiority test will be performed.
Results: Eighty patients were randomly allocated to either BuMA (n¼40) or EXCEL
(n¼40) group. There were no signiﬁcant differences (all p<0.05) with respect to
baseline characteristics, procedural results, and 1-month clinical outcomes between
the two groups (table).acts/POSTER/Intravascular Imaging and PCI B173
Table. Baseline Characteristics, Procedural Results, and 1-Month Clinical
Outcomes
　 BuMA, n=40 EXCEL, n=40 p
Age, years 57.4  9.5 57.1  9.7 0.91
Male, % (n) 87.5 (35) 70.0 (28) 0.06
Prior Myocardial
Infarction, % (n)
27.5 (11) 22.5 (9) 0.61
Unstable Angina, %
(n)
47.5 (19) 47.5 (19) 1.00
Diabetes Mellitus,
% (n)
17.5 (7) 35.0 (14) 0.08
LVEF, % 64.8  5.3 64.4  4.4 0.70
Number of Target
Lesion per Patient,
n
1.15  0.43 1.15  0.36 0.79
Target Lesion
Location, % (n)
　 　 0.53
LAD 56.5 (26) 47.8 (22) 　
LCX 17.4 (8) 15.2 (7) 　
RCA 26.1 (12) 37.0 (17) 　
Reference Vessel
Diameter, mm
2.89  0.52 2.77  0.43 0.21
Lesion Length, mm 16.7  10.0 19.7  11.8 0.29
Predilatation, % (n) 89.1 (41) 80.4 (37) 0.25
Number of Stents
per Patient, n
1.48  0.78 1.58  0.78 0.52
Total Stent Length
per Patient, mm
28.8  17.6 33.6  18.1 0.34
Postdilatation, %
(n)
82.6 (38) 69.6 (32) 0.14
Device Success, %
(n/N)
100 (59/59) 100 (63/63) 1.00
Lesion Success, %
(n/N)
100 (46/46) 100 (46/46) 1.00
Clinical Outcomes
at 1-Month
　 　 　
Death, % (n) 0 (0) 0 (0) N/A
Cardiac Death, %
(n)
0 (0) 0 (0) N/A
Myocardial
Infarction, % (n)
7.5 (3) 7.5 (3) 1.00
Q Wave
Myocardial
Infarction, % (n)
0 (0) 0 (0) N/A
Non Q Wave
Myocardial
Infarction, % (n)
7.5 (3) 7.5 (3) 1.00
Target Vessel
Myocardial
Infarction, % (n)
0 (0) 0 (0) N/A
Ischemia-Driven
Target Lesion
Revascularization,
% (n)
0 (0) 0 (0) N/A
Target Lesion
Failure, % (n)
7.5 (3) 7.5 (3) 1.00
Deﬁnite / Probable
Stent Thrombosis,
% (n)
0 (0) 0 (0) N/A
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coverage between two differently designed BPDES. The primary and major secondary
endpoints will be presented at TCT2013. (ClinicalTrials.gov identiﬁer: NCT
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Background: We examined the association of lipid core plaque (LCP) as detected by
coronary near-infrared spectroscopy (NIRS) with short- and long-term outcomes after
coronary angiography and percutaneous coronary intervention (PCI).
Methods: Between 2009 and 2012 coronary NIRS was performed in 185 coronary
arteries in 162 patients who underwent clinically-indicated cardiac catheterization.
PCI was performed in 132 coronary arteries. LCP was deﬁned as 2 contiguous
yellow blocks on block chemogram. Of the 132 coronaries, 74 had LCP. Short and
long-term outcomes of LCP within (n¼61) and outside (n¼37) the PCI-target lesion
were evaluated. Short-term major adverse cardiac events (MACE) included peri-
procedural myocardial infarction (MI), stroke, death, stent thrombosis and no reﬂow.
Long-term MACE included all-cause mortality, stroke, re-hospitalization for acute
coronary syndrome (ACS), MI, target vessel revascularization and target lesion
revascularization.
Results:Mean age was 628 years, 98% were men. Most presented with ACS (39%)
or stable angina (54%). Median follow-up was 3311 months. Among those receiving
PCI, LCP was present in 74 (56%) of 132 imaged PCI-target vessels; mean lipid core
burden index was 99.565. Incidence of short- (6.1% v 4.6%, p¼1.0) and long-term
(8.4% v 5.5%, p¼0.55) MACE was similar in those with and without LCP who
underwent PCI. Incidence of all-cause death (7.3% v 3.6%, p¼0.69), ACS re-hospi-
talization (13.9% v 18.2%, p¼0.23) were similar with and without LCP.Conclusions:We found no difference in short- or long-term outcomes among patients
who underwent PCI with and without LCP.
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Background: Pathological studies report that acute ST-segment elevation myocardial
infarction (STEMI) is caused not only by plaque rupture but also by other causes, such
as erosion. We sought to assess whether coronary plaque rupture at culprit lesions is
associated with infarct size in patients with STEMI. Some patients with STEMI have
large infarcts despite early reperfusion. Whether culprit plaque morphology impacts
infarct size or not remains unknown.
Methods: Patients who had a ﬁrst STEMI with reperfusion within 12 hours after onset
were enrolled and divided into 2 groups according to the presence or absence of
plaque rupture at the culprit lesion as deﬁned by Optical Coherence Tomogra-
phy(OCT): patients with rupture (n ¼68) and without rupture (n ¼ 35).
Results: Patients with plaque rupture had　higher peak creatine kinase levels (3755
2826 vs. 1768 1593 IU/l ; p < 0.0001) ,creatine kinase-myocardial band were
higher (328  206 vs. 180  175 IU/l ; p ¼ 0.0002). And infarct sizes detected by
contrast-enhanced cardiac magnetic resonance were higher (19.3  11.9 vs. 10.1 
6.0 % ; p <0.0001) in ruptured group than non-ruptured group. Transmural extent of
infarction Grade (TEI-Grade) was grater (p ¼ 0.0001) in ruptured group. The presence
of microvascular obstruction (MVO) was higher (39 vs. 19% ; p ¼ 0.0261) in ruptured
group.
Conclusions: Plaque rupture is associated with morphologic characteristics of
vulnerable lesions, as well as with larger infarcts size.mber 1, 2013 j TCT Abstracts/POSTER/Intravascular Imaging and PCI
